Clinical features and outcomes in kidney transplant recipients with COVID-19 pneumonia: a single center retrospective cohort study
Fever, cough, and myalgia remain common initial symptoms of concurrent COVID-19 pneumonia in KTRs. Early use of antiviral drugs (paxlovid or molnupiravir) is associated with better therapeutic outcomes. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) had a limited impact on the short-term renal function of the KTRs with concurrent moderate or severe COVID-19 pneumonia.
Authors
- Yi Wang (ORCID: https://orcid.org/0000-0002-0558-7491)
- Xiuxiu Chen
- Jianli Wang
- Song Chen (ORCID: https://orcid.org/0000-0001-6412-5740)
- Xuying Yang
- Jian Xu (ORCID: https://orcid.org/0009-0003-0335-2837)
- Zehua Yuan
- Meng Yang (ORCID: https://orcid.org/0000-0001-6439-2873)
- Hongtao Jiang
- Liang Xu
- Rentian Chen
Institutions
- Tianjin First Center Hospital (CN)
- Tianjin Medical University (CN)
- Hainan Medical University (CN)
Publication Details
- Journal
- Frontiers in Cellular and Infection Microbiology
- Published
- 2024-08-15
- DOI
- https://doi.org/10.3389/fcimb.2024.1392491
- Primary Topic
- COVID-19 Clinical Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00